Organigram Global (OGI) Operating Leases (2023 - 2024)
Organigram Global (OGI) reported Operating Leases of $2.5 million for Q3 2024, down 7.46% year-over-year from $2.6 million in Q4 2023, and down 7.46% quarter-over-quarter from $2.6 million in Q3 2023.
Organigram Global (OGI) Operating Leases (2023 - 2024) Analysis & Trends
Organigram Global (OGI) has 2 years of Operating Leases data on file, last reported at $2.5 million in Q3 2024.
- Operating Leases for Q3 2024 came in at $2.5 million, down 7.46% year-over-year; the trailing twelve-month figure through Sep 2024 was $2.5 million (down 7.46% YoY), and the FY2024 annual result was $2.5 million, down 6.65% from the prior year.
- Operating Leases slipped to $2.5 million in Q3 2024 per OGI's latest filing, from $2.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $2.6 million in Q3 2023 and troughed at $2.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.45 Mn |
| Sep 30, 2023 | 2.65 Mn |